1-3 of 3
Emilio Bajetta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens

Kimmie Ng, Josep Tabernero, Jimmy Hwang, Emilio Bajetta, Sunil Sharma, Salvatore A. Del Prete, Edward R. Arrowsmith, David P. Ryan, Michaela Sedova, Jin Jin, Kamel Malek, Charles S. Fuchs
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (14): 3987–3995.
https://doi.org/10.1158/1078-0432.CCR-13-0027
Published: 15 July 2013
View article titled, Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens
Open the PDF for Phase II Study of Everolimus in Patients with Metastatic Colorectal Adenocarcinoma Previously Treated with Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regimens in another window
Journal Articles

Bevacizumab plus Fotemustine as First-line Treatment in Metastatic Melanoma Patients: Clinical Activity and Modulation of Angiogenesis and Lymphangiogenesis Factors

Michele Del Vecchio, Roberta Mortarini, Stefania Canova, Lorenza Di Guardo, Nicola Pimpinelli, Mario R. Sertoli, Davide Bedognetti, Paola Queirolo, Paola Morosini, Tania Perrone, Emilio Bajetta, Andrea Anichini
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (23): 5862–5872.
https://doi.org/10.1158/1078-0432.CCR-10-2363
Published: 06 December 2010
View article titled, Bevacizumab plus Fotemustine as First-line Treatment in Metastatic Melanoma Patients: Clinical Activity and Modulation of Angiogenesis and Lymphangiogenesis Factors
Open the PDF for Bevacizumab plus Fotemustine as First-line Treatment in Metastatic Melanoma Patients: Clinical Activity and Modulation of Angiogenesis and Lymphangiogenesis Factors in another window
Includes: Supplementary data
Journal Articles

Interleukin-12: Biological Properties and Clinical Application

Michele Del Vecchio, Emilio Bajetta, Stefania Canova, Michael T. Lotze, Amy Wesa, Giorgio Parmiani, Andrea Anichini
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (16): 4677–4685.
https://doi.org/10.1158/1078-0432.CCR-07-0776
Published: 15 August 2007
View article titled, Interleukin-12: Biological Properties and Clinical Application
Open the PDF for Interleukin-12: Biological Properties and Clinical Application in another window